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Abstract 
Purpose: The aim of this study was to unravel the link between human leukocyte antigen-G un-
translated region (HLA-G 3-UTR) single-nucleotide polymorphism (SNP) and preeclampsia by 
examining polymorphisms in HLA-G 3-UTR in preeclampsia patients and their newborns, as well as 
those of women with normal pregnancy and their newborns. 
Methods: Single pregnant mothers and their newborns at the Third Affiliated Hospital of Zhengzhou 
University, China, were divided into preeclampsia group (144 cases), and normal pregnancy group (122 
cases). Blood samples from the two groups were collected for DNA extraction, and the DNA samples 
were analyzed for HLA-G 3'-UTR SNP by polymerase chain reaction (RT-PCR) and direct sequencing 
method. 
Results: The frequency of CG genotype in HLA-G 3-UTR 3127 gene in the preeclampsia group was 
significantly lower, while the frequency of AA genotype in HLA-G 3-UTR 3172 gene in the preeclampsia 
group was significantly higher (p < 0.05) when compared with the normal pregnancy group. 
Furthermore, frequencies of the compatible genotype AA/AA (mothers/newborns) in HLA-G 3-UTR 3172 
gene in the preeclampsia group were significantly higher relative to the normal pregnancy group (p< 
0.05).  
Conclusion: These results suggest that when CC/GG is the compatible genotype in HLA-G 3-UTR 
3127 gene of mothers/newborns, preeclampsia risk may decrease, but it may increase if the compatible 
genotype is AA/AA. Thus, SNP in HLA-G 3-UTR 3127 gene may be a protective factor against 
preeclampsia in Chinese Han pregnant women, while SNP in 3172 gene may be associated with 
susceptibility to preeclampsia.  
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Preeclampsia is a hypertensive disorder in 
pregnancy, a multiple organ dysfunction of 
pregnant women during the second and third 
trimesters of pregnancy. It is characterized by 
hypertension, proteinuria and edema 20 weeks 
into pregnancy. The incidence of stroke in China 
is 9.4 %, while in foreign countries it ranges from 
7 to 12 % [1]. Preeclampsia is a major 
contributory factor to pre-natal morbidity and 
mortality [2,3].  
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The pathogenesis of preeclampsia has been 
attributed to different factors. Studies on 
preeclampsia within and outside China have 
tended to focus on factors such as genetic 
susceptibility, immune mal-adaptation, placental 
ischemia and oxidative stress [4]. One of the 
most popular hypotheses posits a relationship 
between the   pathogenesis of preeclampsia and 
abnormal immune tolerance [5,6]. Some scholars 
believe that the embryo carries paternal gene. 
Thus the embryo is homologous graft for mother, 
resulting in an immune reaction between embryo 
and mother [7]. Other researchers are of the view 
that immune tolerance can protect the embryo as 
a homologous graft from rejection by the 
maternal immune system [3,8]. In early 
pregnancy, trophoblast cells may invade the 
myometrium and spiral artery without being 
identified and excluded by the maternal immune 
system. This is associated with MHC expressed 
in trophoblast cells. Human leukocyte antigen 
(HLA-G) which belongs to non-classical MHC-I 
molecules in humans, are highly expressed in 
maternal-fetal extra-villous cytotrophoblast 
(EVCT). HLA-G occupies a crucial place in 
maternal-fetal immune tolerance and the re-
building of placental vessels [5,9,10]. 
 
Polymorphism has been proven in the non-
coding and coding regions of HLA-G. The 
polymorphism in non-coding region of HLA-G 
includes polymorphism in 3-untranslated region 
(3-UTR) and 5-upstream regulatory region (5-
URR). Much attention has been focused in 
recent years on the study of 3-UTR 
polymorphisms. 
 
Research on pregnant women has found a 
single-nucleotide polymorphism (SNP) in HLA-G 
3-UTR involving mutation of normal G in 3172 to 
A [11]. It is believed that 3172 SNP 
polymorphism may be associated with 
preeclampsia, and may be involved in 
stabilization of HLA-G mRNA. Studies on 
newborns showed that this polymorphism is 
associated with severe preeclampsia when the 
neonatal genotype is SNP 2995 (C) / SNP3127 
(G) / SNP3127 (A) / SNP3181 (G) / +14 base 
pair (bp) homozygote. Irrespective of pregnancy 
status (i.e. normal pregnancy or preeclampsia), 
the results were attributed to mother-baby gene 
interaction. Thus it would not be comprehensive 
enough to limit pathogenesis of preeclampsia to 
mother or embryo; a more comprehensive study 
of the pathogenesis must focus on compatible 
genotype of both sides by analyzing mother-baby 
gene interaction. This is due to the fact that 
interaction between mother and embryo may 
influence the status of pregnancy. The present 
study was aimed at a more comprehensive 
approach to the pathogenesis of preeclampsia 
from the relationship between HLA-G 
polymorphism and preeclampsia based on 







From October 2008 to November 2010, pregnant 
women with single embryo, who were attended 
to in the Department of Obstetrics and 
Gynecology at the Third Affiliated Hospital of 
Zhengzhou University, China, were selected for 
the study. These women were randomly divided 
into two groups: preeclampsia group (case 
group) and normal pregnancy group (control 
group).There were 144 cases of pregnant 
women and their newborns in the preeclampsia 
group. The mean age of the pregnant women 
was 31.40 ± 1.76years, and the mean gestational 
period was 34.85 ± 5.14 weeks. In the normal 
pregnancy group, there were 122 cases of 
pregnant women and their newborns. The mean 
age of the pregnant women was 31.39 ± 4.2 
years, while the mean gestational period was 
37.46 ±1.98 weeks. There were significant 
differences between two groups with respect to 
age, pregnancy time, gestational period and 
delivery time (p < 0.05). The pregnant women in 
both groups were Han residents with no 
consanguinity and no history of inter-marriage. 
All of the subjects in the study were monitored for 
12 weeks after delivery. Based on the declaration 
of Helsinki promulgated in 1964 as amended in 
1996 [12], this study was approved by the Ethical 
Committee of The Third Affiliated Hospital of 
Zhengzhou University (approval no. 20100312). 
 
Choice of standard 
 
The inclusive criteria of control group were: full 
term pregnancies, blood pressure lower than 
140/90mm Hg and absence of proteinuria. There 
were no cases of high blood pressure, heart 
disease, kidney disease, liver disease and 
diabetes in pregnant women in the two groupss. 
In addition, they had no history of blood 
transfusions, immunization, or any complications 
of pregnancy. All the pregnant women were 




Genomic DNA was extracted from white blood 
cells obtained from peripheral venous blood 
(2mL of cord blood of pregnant women and their 
embryo from the two groups). Extraction of 
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genomic DNA was carried out using a 
commercial kit. 
 
Expansion of targeted fragments and genetic 
sequencing 
 
Primers: primer sequence 
 
The primer sequences are shown in Table 1. 
 
System and reaction conditions 
 
The targeted fragments were amplified by 
Nested polymerase chain reaction (nPCR. The 
PCR reaction conditions were: pre-denaturation 
at 95oC for 5 min, denaturation at 95°C for 30 s, 
annealing at 68 °C for 30 s, extended at 72°C for 
1 min, a total of 36 cycles, and finally extended at 
72°C for 10 min. The PCR products of HLA-G 3-
UTR were subjected to 2 % agarose 
electrophoresis to comply with the requirements 
of the experimental design (Plate 1). 
 
The first lane is the marker. The second to 
seventh lanes are 6 aimed genes which were 




Fragments of PCR amplification product 245bp 
and 3 SNPs were discovered from the resultant 
sequence. These three different SNPs are 
located in 3127 site, 3172 site and 3181 site, 
which lie in HLA-G exon 8 3-UTR. The PCR 
products were sequenced by reverse 
sequencing. The tables of sequence obtained 
were reverse and complementary sequences, 
which meant that the site in T peak should be 
interpreted as A, and the site in G peak should 
be interpreted as C. The tables of sequence from 





Software SPSS 16.0 was used to analyze all 
data to determine if the genotypic distribution 
was in Hardy-Weinberg equilibrium. For analysis 
of measurement data, t-test was used to 
compare the two groups. Non-normal distribution 
measurement data were compared with rank 
sum test. Differences in genotype distribution 
were tested by Chi-Square test method of 
Fourfold table where n ≥ 40 and theoretical 
frequency (T) ≥ 5; ordinary Chi-Square test was 
used where n ≥ 40 but 1 ≤ T < 5, corrective Chi-
Square test was used; where n < 40 or T < 1, 
Fisher definite probability method was employed. 




Results of analysis of SNP genotype frequency 
distributions of HLA-G 3-UTR in pregnant women 
and embryos from the preeclampsia and normal 
pregnancy groups satisfied the law of Hardy-
Weinberg equilibrium (p > 0.05). Thus the 
method is suitable for analysis of HLA-G 3-UTR 
SNP genotype distributions. The study showed 
that in HLA-G 3-UTR, three single-nucleotide 
polymorphisms in HLA-G 3-UTR occurred at site 
3127 (rs1063320, C→G); site 3172 site 
(rs9380142, G→A), and site 3181 site 
(rs1610696, C→G). 
 
Table 1: PCR primer sequence of genes 
 
Gene Primer sequence Amplification products 
HLA-G 3-UTR  Primers  245 
Upstream GGGATGTCTCCGTCTCTGTC  
Downstream GGGATGTCTCCGTCTCTGTC  
β-actin  548 
Upstream GTGGGGCGCCCCAGGCACCA  
Downstream GTCCTTAATGTCACGCACGATTTC  
 
 
Plate 1: Amplification products of HLA-G 3-UTR SNP and the results of agarose electrophoresis.1st lane: 
Marker; 2nd-7th lanes: aimed genes chosen at random (245bp) 
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Figure 1: Genotype of SNP 3127 site. a: Genotype of SNP 3127 site: CC; b: Genotype of SNP 3127 
site: GC; c: Genotype of SNP 3127 site: GG; d: Genotype of SNP 3172 site: AA; e: Genotype of SNP 
3172 site: AG; f: Genotype of SNP 3172 site: GG; g: Genotype of SNP 3181 site: CC; h: Genotype of 
SNP 3181 site: CG; i: Genotype of SNP 3181 site: GG. The yellow area means the mutation location 
 
Comparison of HLA-G 3-UTR SNP 3127 
genotype and allele frequencies 
 
Comparison of HLA-G 3-UTR SNP 3127 
genotype and allele frequencies of pregnant 
women from the two groups 
 
In HLA-G 3-UTR 3127 site, two alleles G and C, 
and three genotypes CG, CC and GG existed. 
The frequency of site G allele in HLA-G 3-UTR 
3127 in the preeclampsia group was 47.2 % and 
the C allele frequency was 52.8 %. G allele 
frequency in normal pregnancy group was 52.0 
%, while the C allele frequency was 48.0 %. 
There was no significant difference in the C and 
G allele distribution between the two groups (p > 
0.05). HLA-G 3-UTR 3127 site CG genotype 
frequency in the preeclampsia group was 45.3 
%, which was significantly lower than that in the 
normal pregnancy group (64.7 %, p > 0.05, Table 
2). 
 
Comparison of embryo HLA-G 3-UTR SNP 
3127 genotype and allele frequencies from 
the two groups 
 
Two alleles were found in HLA-G 3-UTR 3127 
site: G and C, as well as 3 genotypes: CG, CC 
and GG. The frequency distributions of these 
alleles and genotypes are shown in Table 3. In 
the preeclampsia group, G allele frequency was 
46.9%, while the C allele frequency was 53.1%. 
The G allele frequency in normal pregnancy 
group was 45.1% while the C allele frequency 
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was 54.9%. No significant difference in the two 
allele frequencies was found between the two 
groups (χ2 = 0.044, p = 0.833 > 0.05). In addition, 
no significant difference in genotype distribution 
frequencies was found between the two groups 
(p > 0.05). 
 
Comparison of mother/embryo HLA-G 3-UTR 
SNP 3127 compatible genotype between the 
two groups 
 
There was no significant difference in mother/ 
embryo HLA-G 3-UTR SNP 3127 compatible 
genotype between the two groups (p > 0.05, 
Table 4). 
 




(n = 53)  
Normal pregnancy group 
(n = 51) χ2 P 
N Frequency (%)  N 
Frequency 
(%) 
Allele        
C 56 52.8  49 48.0   
G 50 47.2  53 52.0 0.477 0.490 
Summation 106 100  102 100   
genotype        
CC 16 30.2  8 15.9 3.079 0.079 
CG 24 45.3  33 64.7 3.959 0.047 
GG 13 24.5  10 19.6 0.365 0.546 
Summation 53 100  51 100   
 
Table 3: Comparison of HLA-G 3-UTR 3127 SNP in embryo of the preeclampsia and normal pregnancy groups 
 
HLA-G 
Preeclampsia group  
(n=32)  
Normal pregnancy group 
(n=41) χ2 P 
N Frequency(%)  N Frequency(%) 
Allele        
C 34 53.1  45 54.9   
G 30 46.9  37 45.1 0.044 0.833 
Summation 64 100  82 100   
genotype        
CC 7 21.9  9 22.0 0.000 0.994 
CG 20 62.5  27 65.9 0.088 0.767 
GG 5 15.6  5 12.1 0.006 0.936* 
Summation 32 100  41 100   
* Corrective Chi-square test used 
 
Table 4: Analysis of mother/embryo HLA-G 3-UTR 3127 SNP compatible genotype frequencies in the 










 (n = 27) 
 Normal 
pregnancy 
 (n =35) χ2 P 
N Frequency (%) 
 N Frequency (%) 
CC CC 2 7.4  1 2.9 0.685 0.408* 
 CG 7 25.9  2 5.7 3.521 0.061* 
 GG 1 3.7  0 0 -- 0.435# 
CG CC 1 3.7  6 17.1 1.571 0.210* 
 CG 8 29.6  16 45.7 1.662 0.197 
 GG 1 3.7  2 5.7 0.000 1.000* 
GG CC 2 7.4  1 2.9 0.053 0.817* 
 CG 5 18.5  5 14.3 0.010 0.919* 
 GG 1 3.7  1 2.9 -- 1.000# 
# With definite probability methods;* with corrective Chi-Square test 
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Comparison of HLA-G 3-UTR 3172 genotype 
and allele frequencies 
 
Comparison of HLA-G 3-UTR SNP 3172 
genotype and allele frequencies of pregnant 
women from the two groups 
 
In HLA-G 3-UTR 3172 site, two alleles (G and A), 
and three genotypes (AG, AA and GG) were 
present. The G allele frequencies in the 
preeclampsia and normal pregnancy groups 
were 42.5 and 36.3%, respectively, while the A 
allele frequencies in the preeclampsia and 
normal pregnancy groups were 57.5 and 63.7%, 
respectively. Between the two groups, no 
significant differences were found (χ2 = 0.831, p 
= 0.362 > 0.05). The frequency of AA genotype 
in the preeclampsia group (50.9%) was 
significantly higher than that in the normal 
pregnancy group (25.5%, p < 0.05; Table 5). 
 
Comparison of HLA-G 3-UTR SNP 3172 
genotype and allele frequencies of embryo 
from the two groups 
 
In HLA-G 3-UTR 3172 site, two alleles: G and A; 
and three genotypes: AG, AA and GG were 
present. The frequencies of G allele in the 
preeclampsia and normal pregnancy groups 
were 45.3 and 43.9%, respectively. The 
frequencies of the A allele in the preeclampsia 
and normal pregnancy groups were 54.7 and 
56.1%, respectively. There were no significant 
differences in allele frequencies between the two 
groups (p > 0.05). Moreover, there were no 
significant differences in genotype distribution 
frequencies between the two groups (p > 0.05, 
Table 6). 
 
Comparison of mother/ embryo HLA-G 3-UTR 
SNP 3172 compatible genotype between the 
two groups 
 
The frequency of compatible AA/AA genotype 
frequency of mother/ embryo HLA-G 3-UTR 3172 
site in the preeclampsia group (55.6%) was 
significantly higher (p < 0.05) than that in the 
normal pregnancy group (28.6%, Table 7). 
 
Comparison of HLA-G 3-UTR SNP 3181 
genotype and allele frequencies 
 
Comparison of HLA-G 3-UTR SNP 3181 
Genotype and allele frequencies of pregnant 
women from the two groups 
 
There were 2 alleles (G & C) and 3 genotypes 
(CG, CC & GG) in HLA-G 3-UTR 3181 site. 
 





(n = 53)  
Normal pregnancy group 
(n = 51) χ2 P 
N Frequency (%)  N Frequency (%) 
Allele        
A 61 57.5  65 63.7   
G 45 42.5  37 36.3 0.831 0.362 
Summation 106 100  102 100   
genotype        
AA 27 50.9  13 25.5 7.114 0.008 
AG 17 32.1  21 41.2 0.928 0.335 
GG 9 17.0  17 33.3 3.706 0.054 
Summation 53 100  51 100   
 





(n = 32)  
Normal pregnancy group  
(n = 41) χ2 P 
N Frequency (%)  N Frequency (%) 
Allele        
A 35 54.7  46 56.1   
G 29 45.3  36 43.9 0.029 0.865 
Summation 64 100  82 100   
Genotype        
AA 7 21.9  11 26.9 0.237 0.626 
AG 21 65.6  24 58.5 0.382 0.537 
GG 4 12.5  6 14.6 0.000 1.000* 
Summation 32 100  41 100   
* With corrective Chi-Square test 
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(n = 27)  
Normal pregnancy 
group (n = 35) χ2 P 
N Frequency (%)  N 
Frequency 
(%) 
AA AA 15 55.6  10 28.6 4.612 0.032 
 AG 1 3.7  7 20.0 2.298 0.130* 
 GG 2 7.4  1 2.9 0.053 0.817* 
AG AA 2 14.8  3 8.6 0.134 0.715* 
 AG 2 7.4  5 14.3 0.197 0.657* 
 GG 1 3.7  4 11.4 0.406 0.524* 
GG AA 0 0  1 2.9 -- 1.000# 
 AG 3 11.1  4 11.4 0.000 1.000* 
 GG 1 3.7  0 0 -- 0.435# 
# With definite probability method;* with corrective Chi-square test 
 
No significant difference in G allele frequencies 
was found between the preeclampsia group 
(33.0%) and the normal pregnancy group 
(36.3%, p > 0.05). Similarly, there was no 
significant difference in C allele frequency 
between the normal pregnancy group (63.7%) 
and the C allele frequency in the preeclampsia 
group (67.0%, p > 0.05; Table 8). 
 
Comparison of HLA-G 3-UTR SNP 3181 
genotype and allele frequencies in embryos 
from the two groups 
 
The G allele frequencies in embryos in the 
preeclampsia and normal pregnancy groups 
were 20.7 and 34.1%, respectively, while the 
corresponding frequencies of the C allele were 
57.3 and 65.9 %, respectively (p > 0.05; Table 
9). 
 





(n = 53)  
Normal pregnancy group 
(n = 51) χ2 P 
N Frequency (%)  N Frequency (%) 
Allele        
C 71 67.0  65 63.7   
G 35 33.0  37 36.3 0.243 0.622 
Summation 106 100  102 100   
genotype        
CC 22 41.5  17 33.3 0.741 0.389 
CG 27 50.9  31 60.8 1.020 0.312 
GG 4 7.6  3 5.9 0.00 1.000* 
Summation 53 100  51 100   
* With corrective Chi-square test 
 





(n = 32)  
Normal pregnancy group 
(n = 41) Χ2 P 
N Frequency (%)  N Frequency (%) 
Allele        
C 47 57.3  54 65.9   
G 17 20.7  28 34.1 0.970 0.865 
Summation 64 100  82 100   
genotype        
CC 15 46.9  15 36.6 0.786 0.375 
CG 17 53.1  24 58.5 0.214 0.644 
GG 0 0  2 4.9  1.000# 
Summation 32 100  41 100   
* With corrective Chi-square test 
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N Frequency (%)  N 
Frequenc
y(%) 
CC CC 5 18.5  5 14.3 0.010 0.919* 
 CG 9 33.3  5 14.3 3.163 0.075 
 GG 0 0  1 2.9 -- 1.000# 
CG CC 7 25.9  8 22.9 0.078 0.780 
 CG 4 14.8  14 40.0 4,.692 0.030 
 GG 0 0  0 0 -- -- 
GG CC 0 0  0 0 -- -- 
 CG 2 7.4  2 5.7 0.000 1.000* 
 GG 0 0  0 0 -- -- 
# With definite probability methods;* with corrective Chi-square test 
 
Comparison of mother/embryo HLA-G 3-UTR 
SNP 3181 compatible genotype between the 
two groups 
 
The frequency of compatible CC/GG genotype in 
mother/embryo HLA-G 3-UTR 3181 site in the 
preeclampsia group (14.8%) was significantly 
lower than that in normal pregnancy group 




In this study, 3 SNPs were discovered in HLA-G 
exon 8 3-UTR. The three different SNPs were 
located in 3127 site (rs1063320), 3172 site 
(rs9380142) and 3181 site (rs1610696). 
 
This study has demonstrated that the frequency 
of SNP 3127 site CG genotype in pregnant 
women with preeclampsia (45.3 %) was 
significantly lower than that in normal pregnancy 
group (64.7 %). However there was no significant 
difference in compatible genotype distributions 
between the two groups. Consequently, it can be 
concluded that women with CG genotype in HLA-
G 3-UTR SNP 3127 site have lower risk of 
preeclampsia. There was no difference in SNP 
3127 genotype frequency distributions in 
newborn between the two groups. This is 
contrary to the results of Larsen, who reported 
significant differences in CG genotype 
distributions between Caucasian preeclampsia 
and normal pregnancy groups [13]. This 
difference might be due to the differences in 
ethnic groups and geographic regions. 
 
The significant difference in AA genotype 
frequencies between the preeclampsia and 
normal pregnancy groups is in agreement with 
the findings of Yie [12]. Since pregnancy is a 
special physiological state, these results, 
whether in preeclampsia or normal pregnancy, 
are most likely due to mother-baby gene 
interaction. In effect, the pathogenic gene could 
be from mother or from the embryo. 
Consequently, combination analysis of 
compatible genotype between mother and 
embryo may provide insight into the 
pathogenesis of preeclampsia. In this study, it 
was found from analysis of mother/ embryo 
compatible genotype that the frequencies of 
mother/ embryo compatible AA/ AA genotype in 
the preeclampsia group was higher than the 
frequency in normal pregnancy group. This 
strongly suggests that HLA-G 3-UTR SNP 3172 
may be a pre-disposing gene for preeclampsia, 
and may increase risk of preeclampsia. However, 
there were no significant differences in genetic 
polymorphisms between newborns in the two 
groups. This is consistent with the results of 
Larsen [12]. In Caucasian newborn the A allele 
occurs primarily in normal pregnancy rather than 
in preeclampsia. Moreover there was no 
significant difference in HLA-G 3-UTR 3172 
genotype between the two groups. 
 
It is believed that HLA-G 3172 site is near to an 
AUUA motif [12]. The AU motif is a sequence 
which consists of uridylic acid and some 
adenosine, a kind of cis-acting degradation 
signal which can encode cytokines, growth 
factors and other regulating proteins. It also 
influences the stability of 3-UTR mRNAs [14, 15]. 
It has been established that A allele can reduce 
the stability of HLA-G mRNAs [12]. Therefore 
mutation in this site reduces the level of mRNA 
and then causes changes in transcription and 
translation, leading to decreased HLA-G protein 
expression. This reduces maternal-fetal immune 
tolerance, and also reduces physical protective 
reaction between mother and baby. In addition, it 
decreases the invasive ability of trophoblast 
cells. Superficial implantation of placenta causes 
ischemia and placental hypoxia.  
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Figure 2: HLA-G mRNA 3’-UTR sequence: 3’-UTR G→A near to AU-motif 
 
Oxidative stress and lipid peroxidation arise in 
local placenta. The cells of intervillous space are 
activated and endothelium is damaged, all of 
which ultimately lead to preeclampsia. 
 
The results of this research show no significant 
difference in HLA-G SNP 3182 polymorphisms 
between mother and embryo in the two groups. 
This finding agrees with that of Larsen [13]. In 
Caucasian newborn, the frequency of CG/ CG 
genotype in mother/ embryo 3181 site in the 
preeclampsia group was lower than that in the 
normal pregnancy group. This implies that 
populations with mother/embryo compatible 
genotype (CG/CG) in HLA-G 3181 site have 
lower risk of preeclampsia. 
 
However some researchers believe that there is 
complete linkage disequilibrium between HLA-G 
14bp allele and the three SNPs (SNP 2995, SNP 
3127 and SNP 3172). SNP 3172 and SNP 3181 
are on the right side of AU-motif which is 
associated with the stability of mRNA. When 
14bp deletion polymorphism is combined with 
SNP 3127, it is linked to primipara with severe 
preeclampsia. Research has shown that HLA-G 
14bp deletion polymorphism is a special 
genotype of exon 8. When embryo genotype is 
SNP2995 (C) / SNP3127 (G) / SNP3172 (A) / 
SNP3181 (G) / +14bp homozygotes, it is 
associated with primipara with severe 
preeclampsia. Therefore it is important to study 
the relationship between HLA-G 3-UTR 
polymorphism and preeclampsia from linkage 
dis-equilibrium, analyze the impact of SNP 
polymorphism near to AU-motif on the stability of 
mRNA, and the impact of the HLA-G protein 




This study has demonstrated that there might be 
a relationship between HLA-G 3-UTR SNP 3172 
polymorphism and susceptibility to preeclampsia 
in China Henan Han population. It has shown 
that preeclampsia is a disease of abnormal 
immune tolerance between mother and embryo, 
and provided new empirical evidence for 
pathogenesis of the disease. The results also 
provide an important clue for predicting likelihood 
of preeclampsia, as well as prospects for gene 
therapy by analyzing differences in compatible 
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